中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共1条，第1-1条 帮助

已选(0)清除 条数/页：   排序方式：
Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Guo, Weijian;  Zhu, Xiaodong;  Huang, Mingzhu;  Wang, Yusheng;  Chen, Zhiyu;  Feng, Wanjing;  He, Yifu;  Zhang, Xiaowei;  Liu, Xin;  Wang, Chenchen;  Zhang, Wen;  Ying, Jieer;  Wu, Jun;  Yang, Lei;  Qin, Yanru;  Zhao, Xiaoying;  Li, Wenhua;  Zhang, Zhe;  Qiu, Lixin;  Wang, XiaoFeng
收藏  |  浏览/下载：51/0  |  提交时间：2022/01/10